Cellular protoonocogenes are infrequently amplified in untreated non-small cell lung cancer.

Por Slebos, R. J., Evers, S. G., Wagenaar, S. S., Rodenhuis, S.
Publicado em 1989

High-dose chemotherapy in breast cancer: Dutch randomized studies

Por Rodenhuis, S, van Tinteren, H, de Vries, EGE
Publicado em 2001

Invasive aspergillosis complicated by subclavian artery occlusion and costal osteomyelitis after autologous bone marrow transplantation.

Por Vlasveld, L T, Delemarre, J F, Beynen, J H, Rodenhuis, S
Publicado em 1992

Invasive pulmonary aspergillosis in a non-immunosuppressed patient: successful management with systemic amphotericin and flucytosine and inhaled amphotericin.

Por Rodenhuis, S, Beaumont, F, Kauffman, H F, Sluiter, H J
Publicado em 1984

Flavivirus Cell Entry and Membrane Fusion

Por Smit, Jolanda M., Moesker, Bastiaan, Rodenhuis-Zybert, Izabela, Wilschut, Jan
Publicado em 2011

Detection of minimal disease in breast cancer

Por Bosma, AJ, Helgason, H, Braaf, L, Rodenhuis, S, van 't Veer, LJ
Publicado no Breast Cancer Res (2005)

Ongoing Remission Nineteen Years after High-dose Chemotherapy for Oligometastatic Breast Cancer; What Can We Learn from this Patient?

Por Steenbruggen, Tessa G, Linn, Sabine C, Rodenhuis, Sjoerd, Sonke, Gabe S
Publicado no Cureus (2015)

High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy

Por de Jonge, M E, Huitema, A D R, Beijnen, J H, Rodenhuis, S
Publicado em 2006

Toxicity of the high-dose chemotherapy CTC regimen (cyclophosphamide, thiotepa, carboplatin): the Netherlands Cancer Institute experience

Por Schrama, J G, Holtkamp, M J, Baars, J W, Schornagel, J H, Rodenhuis, S
Publicado em 2003

Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients

Por Weigelt, B, Bosma, A J, Hart, A A M, Rodenhuis, S, van 't Veer, L J
Publicado em 2003

Identifying subgroup markers in heterogeneous populations

Por de Ronde, Jorma J., Rigaill, Guillem, Rottenberg, Sven, Rodenhuis, Sjoerd, Wessels, Lodewyk F. A.
Publicado em 2013

Central venous catheter associated thrombosis of major veins: thrombolytic treatment with recombinant tissue plasminogen activator.

Por Rodenhuis, S, van't Hek, L G, Vlasveld, L T, Kröger, R, Dubbelman, R, van Tol, R G
Publicado em 1993

Population pharmacokinetics of orally administered paclitaxel formulated in Cremophor EL

Por de Jonge, Milly E, Huitema, Alwin DR, Schellens, Jan HM, Rodenhuis, Sjoerd, Beijnen, Jos H
Publicado em 2005

Pharmacokinetics and pharmacodynamics of carboplatin administered in a high-dose combination regimen with thiotepa, cyclophosphamide and peripheral stem cell support.

Por van Warmerdam, L. J., Rodenhuis, S., van der Wall, E., Maes, R. A., Beijnen, J. H.
Publicado em 1996

prM-antibody renders immature West Nile virus infectious in vivo

Por Colpitts, Tonya M., Rodenhuis-Zybert, Izabela, Moesker, Bastiaan, Wang, Penghua, Fikrig, Erol, Smit, Jolanda M.
Publicado em 2011

Early Events in Chikungunya Virus Infection—From Virus Cell Binding to Membrane Fusion

Por van Duijl-Richter, Mareike K. S., Hoornweg, Tabitha E., Rodenhuis-Zybert, Izabela A., Smit, Jolanda M.
Publicado no Viruses (2015)

Breast Cancer Subtype Specific Classifiers of Response to Neoadjuvant Chemotherapy Do Not Outperform Classifiers Trained on All Subtypes

Por de Ronde, Jorma J., Bonder, Marc Jan, Lips, Esther H., Rodenhuis, Sjoerd, Wessels, Lodewyk F. A.
Publicado em 2014

Human macrophages differentiated in the presence of vitamin D(3) restrict dengue virus infection and innate responses by downregulating mannose receptor expression

Por Arboleda Alzate, John F., Rodenhuis-Zybert, Izabela A., Hernández, Juan C., Smit, Jolanda M., Urcuqui-Inchima, Silvio
Publicado no PLoS Negl Trop Dis (2017)

Absence of ras gene mutations in early gastric carcinomas.

Por Craanen, M E, Blok, P, Top, B, Boerrigter, L, Dekker, W, Offerhaus, G J, Tytgat, G N, Rodenhuis, S
Publicado em 1995

Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa

Por Ekhart, Corine, Doodeman, Valerie D, Rodenhuis, Sjoerd, Smits, Paul H M, Beijnen, Jos H, Huitema, Alwin D R
Publicado em 2009